UK markets close in 5 hours 52 minutes

Kezar Life Sciences, Inc. (KZR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.8220+0.0320 (+4.05%)
At close: 04:00PM EDT
0.8008 -0.02 (-2.58%)
After hours: 06:58PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
7,000
0
0
0
Operating expenses
Research development
45,931
85,697
51,009
38,935
30,981
Selling general and administrative
19,300
26,540
20,153
15,724
11,969
Total operating expenses
65,231
112,237
71,162
54,659
42,950
Operating income or loss
-65,231
-105,237
-71,162
-54,659
-42,950
Interest expense
995
1,550
1,185
159
0
Total other income/expenses net
-6,187
-6,187
-
-
-
Income before tax
-64,270
-101,870
-68,239
-54,630
-41,742
Income from continuing operations
-64,270
-101,870
-68,239
-54,630
-41,742
Net income
-64,270
-101,870
-68,239
-54,630
-41,742
Net income available to common shareholders
-64,270
-101,870
-68,239
-54,630
-41,742
Basic EPS
-1.21
-
-1.01
-1.04
-0.95
Diluted EPS
-1.21
-
-1.01
-1.04
-0.95
Basic average shares
72,440
-
67,369
52,759
44,004
Diluted average shares
72,440
-
67,369
52,759
44,004